Otero Jose Manuel 4

What Happened
Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics, sold 3,016 shares in an open-market transaction on 2026-02-18. The weighted-average sale price was $6.40 per share, for total proceeds of approximately $19,294. The filing notes the sale was to cover tax obligations on the release of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-02-18; filing date: 2026-02-20 (appears to be filed within the usual two-business-day window).
• Price: weighted-average $6.40; individual trades ranged from $6.22 to $6.47 (footnote F2).
• Shares sold: 3,016; total proceeds ≈ $19,294.
• Reason: sale to cover tax obligations on RSU release (footnote F1).
• Holdings note: filing indicates holdings include 104,216 Restricted Stock Units (footnote F3). The filing does not list a separate total "shares owned after transaction" in the summary provided here.
• No indication of a 10b5-1 plan or late filing flag in the materials provided.

Context
This was a sale to satisfy tax withholding on RSUs, a common administrative transaction that does not necessarily indicate a change in the insider’s view of the company. Sales for tax withholding are routine and should be interpreted differently from discretionary open-market sales intended to liquidate positions.